Opioid Free Versus Opioid Based General Anesthesia in Septoplasty Under Nociception Level Guidance
1 other identifier
observational
150
1 country
1
Brief Summary
Prospactive observational Clinical study
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedFirst Submitted
Initial submission to the registry
August 19, 2026
CompletedFirst Posted
Study publicly available on registry
August 26, 2026
CompletedAugust 26, 2026
August 1, 2026
1.5 years
August 19, 2026
August 21, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Comparison of Opioid-Free Versus Opioid-Based Anesthesia on Postoperative Pain and Recovery in Patients Undergoing Septal Surgery
Primary Outcome Measure Outcome Measure Title: Postoperative pain intensity measured by the Numeric Rating Scale (NRS) at 15 minutes after surgery Description: Postoperative pain intensity will be assessed using the 11-point Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). Pain scores will be recorded at 15 minutes after surgery and will be summarized for each treatment group using mean ± standard deviation or median and interquartile range, as appropriate. Time Frame: 15 minutes after surgery Secondary Outcome Measures Outcome Measure Title: Postoperative pain intensity measured by the Numeric Rating Scale (NRS) at 1 hour after surgery Description: Pain intensity will be assessed using the 11-point Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). Scores will be summarized for each treatment group using mean ± standard deviation or median and interquartile range, as appropriate. Time Frame: 1 hour after surge
18 months
Study Arms (1)
OFA OBA
Interventions
Eligibility Criteria
septoplasty patients
You may qualify if:
- Adult patients aged 18 years or older
- American Society of Anesthesiologists (ASA) physical status I-III
- Patients scheduled for elective septal surgery under general anesthesia
- Ability to provide written informed consent
- Ability to understand and use the Numeric Rating Scale (NRS) for postoperative pain assessment
You may not qualify if:
- Patient refusal to participate
- Known allergy or hypersensitivity to any of the study medications
- Contraindication to general anesthesia
- Pre-existing chronic opioid use or chronic pain requiring regular analgesic treatment
- Significant psychiatric or neurological disease that could interfere with postoperative pain assessment
- Inability to understand or reliably report pain using the Numeric Rating Scale
- Pregnancy
- Significant hepatic or renal dysfunction
- Any medical condition considered by the investigators to make participation inappropriate or unsafe
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
GH Drama
Drama, Καβάλας, 65403, Greece
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Rafail Ioannidis, MD/PhD/MSC, Anesthesiologist-Pain Specialist
Study Record Dates
First Submitted
August 19, 2026
First Posted
August 26, 2026
Study Start
January 1, 2024
Primary Completion
June 30, 2025
Study Completion
June 30, 2025
Last Updated
August 26, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will share